🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the service has taken down violative content and banned related keywords and query recommendations. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.

After moments of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Product Information and Pricing

Inside these groups, posts show dark colored parcels with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant medical dangers”.